Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Value of Regadenoson Stress Perfusion CMR.

Medical sciences (Basel, Switzerland)·2026
Same author

Consensus statement on obesity management in liver transplantation candidates.

Updates in surgery·2026
Same author

Detection of coronary artery calcifications with low-dose thoracic computed tomography and cardiovascular events in liver transplant recipients.

Revista espanola de enfermedades digestivas·2026
Same author

Comparative Efficacy of Metabolic/Bariatric Surgery Versus GLP-1 Receptor Agonists: A Network Meta-Analysis of Randomized Controlled Trials.

Obesity (Silver Spring, Md.)·2025
Same author

Non-Invasive Myocardial Work Detects Extensive Coronary Disease in Orthotopic Heart Transplant Patients.

Medical sciences (Basel, Switzerland)·2025
Same author

Definition of lines of treatment in metastatic colorectal cancer: a Delphi consensus.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2025

Related Experiment Video

Updated: Jun 14, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

229

Neoadjuvant Statistical Algorithm to Predict Individual Risk of Relapse in Patients with Resected Liver Metastases

Ángel Vizcay Atienza1, Olast Arrizibita Iriarte2, Oskitz Ruiz Sarrias2

  • 1Department of Medical Oncology, Clínica Universidad de Navarra, 31008 Pamplona, Spain.

Biomedicines
|August 29, 2024
PubMed
Summary
This summary is machine-generated.

This study developed a mathematical algorithm to predict relapse risk in colorectal cancer patients with liver metastases, improving personalized treatment strategies. The model demonstrated high accuracy in identifying patients likely to relapse after surgery.

Keywords:
colorectal cancer (CRC)gradient boosting machine (GBM)liver metastases (LM)statistical algorithmssynthetic data

More Related Videos

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
04:22

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis

Published on: March 3, 2023

377
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Related Experiment Videos

Last Updated: Jun 14, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

229
Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
04:22

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis

Published on: March 3, 2023

377
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Area of Science:

  • Oncology
  • Mathematical Modeling
  • Surgical Oncology

Background:

  • Liver metastases (LM) are a primary cause of mortality in colorectal cancer (CRC).
  • Existing prognostic nomograms for CRC with LM have limited accuracy.
  • High relapse rates persist despite advancements in neoadjuvant therapy.

Purpose of the Study:

  • To develop an interpretable neoadjuvant algorithm for predicting individual relapse risk in CRC patients with LM.
  • To ensure mathematical transparency and auditability in risk prediction.
  • To enhance personalized adjuvant therapy and follow-up strategies.

Main Methods:

  • Retrospective evaluation of 86 CRC patients with LM treated with neoadjuvant therapy and resection.
  • Analysis of 155 patient variables, utilizing logistic regression (LR) and gradient boosting machine (GBM).
  • Inclusion of synthetic data to address data limitations and external validation.

Main Results:

  • The GBM model, trained on 74 patients, achieved an accuracy of 0.82, sensitivity of 0.59, and specificity of 0.96 in predicting relapse.
  • Five-year relapse-free survival (RFS) was 33%, and 5-year overall survival (OS) was 60.7%.
  • External validation confirmed the model's promising predictive performance.

Conclusions:

  • The developed algorithm provides an accurate alternative for predicting individual relapse risk in CRC patients with LM.
  • This tool can guide personalized adjuvant therapy decisions.
  • Improved risk stratification can optimize follow-up strategies for better patient outcomes.